Empagliflozin-Loaded Floating Density-Modulated Drug Delivery System As a Novel Approach for Sustained Therapy in Type 2 Diabetes Mellitus With Sodium-Glucose Co-Transporter-2 Inhibition . CDF 2025, 54 (3), 4357-4368. https://doi.org/10.48047/wsqnzm52.